Forgiveness of non-adherence to HIV-1 antiretroviral therapy - PubMed (original) (raw)
Review
doi: 10.1093/jac/dkn020. Epub 2008 Feb 6.
Affiliations
- PMID: 18256112
- DOI: 10.1093/jac/dkn020
Review
Forgiveness of non-adherence to HIV-1 antiretroviral therapy
Jonathan Shuter. J Antimicrob Chemother. 2008 Apr.
Abstract
Superior adherence to HIV-1 antiretroviral therapy is a mainstay of successful HIV management. Studies performed in the early era of highly active antiretroviral therapy demonstrated the need for > or =95% adherence in order to achieve and sustain viral suppression. High rates of viral suppression have been observed at more moderate levels of adherence with newer antiretroviral regimens. The term 'forgiveness' is being used to describe the ability of a regimen to achieve and sustain viral suppression, despite suboptimal adherence. A variety of pharmacological, viral and host properties determine the level of forgiveness of any specific regimen. As the choice of treatment options continues to expand, forgiveness of non-adherence is likely to emerge as an increasingly important factor in therapeutic decision-making.
Similar articles
- Predicting and monitoring antiretroviral adherence.
Gross R. Gross R. LDI Issue Brief. 2007 Nov-Dec;13(2):1-4. LDI Issue Brief. 2007. PMID: 18354853 - [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
Slama L, Le Camus C, Amiel C, Pialoux G, Gharakhanian S. Slama L, et al. Med Mal Infect. 2006 Jan;36(1):16-26. doi: 10.1016/j.medmal.2005.10.003. Epub 2005 Dec 1. Med Mal Infect. 2006. PMID: 16325363 Review. French. - "Solving the puzzle" of current HAART: what key strategic trials are needed?
Carosi G, Torti C. Carosi G, et al. New Microbiol. 2004 Apr;27(2 Suppl 1):127-30. New Microbiol. 2004. PMID: 15646075 - [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish. - Strategies for improving patient adherence to therapy and long-term patient outcomes.
Battaglioli-DeNero AM. Battaglioli-DeNero AM. J Assoc Nurses AIDS Care. 2007 Jan-Feb;18(1 Suppl):S17-22. doi: 10.1016/j.jana.2006.11.020. J Assoc Nurses AIDS Care. 2007. PMID: 17275718
Cited by
- [Compliance enhancement in drug therapy : opportunities and limitations].
Krolop L, Jaehde U. Krolop L, et al. Internist (Berl). 2012 Jan;53(1):99-107. doi: 10.1007/s00108-011-2951-z. Internist (Berl). 2012. PMID: 22119908 German. - The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.
Rosenblum M, Deeks SG, van der Laan M, Bangsberg DR. Rosenblum M, et al. PLoS One. 2009 Sep 29;4(9):e7196. doi: 10.1371/journal.pone.0007196. PLoS One. 2009. PMID: 19787058 Free PMC article. - Development of In Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection.
Tanaudommongkon I, Tanaudommongkon A, Dong X. Tanaudommongkon I, et al. Pharmaceutics. 2021 Jun 18;13(6):904. doi: 10.3390/pharmaceutics13060904. Pharmaceutics. 2021. PMID: 34207272 Free PMC article. - Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States.
Lesko CR, Nance RM, Lau B, Fojo AT, Hutton HE, Delaney JAC, Crane HM, Cropsey KL, Mayer KH, Napravnik S, Geng E, Mathews WC, McCaul ME, Chander G; CNICS. Lesko CR, et al. AIDS Behav. 2021 Apr;25(4):1072-1082. doi: 10.1007/s10461-020-03065-z. Epub 2020 Oct 16. AIDS Behav. 2021. PMID: 33064249 Free PMC article. - Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.
Been SK, van de Vijver DA, Nieuwkerk PT, Brito I, Stutterheim SE, Bos AE, Wolfers ME, Pogány K, Verbon A. Been SK, et al. PLoS One. 2016 Oct 5;11(10):e0162800. doi: 10.1371/journal.pone.0162800. eCollection 2016. PLoS One. 2016. PMID: 27706251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials